JAAHA Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frimberger, A.
Right arrow Articles by Bengtson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frimberger, A.
Right arrow Articles by Bengtson, A.
Journal of the American Animal Hospital Association, Vol 33, Issue 4, 320-324
Copyright © 1997 by American Animal Hospital Association

Articles

Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993)

AE Frimberger, AS Moore, SM LaRue, JM Gliatto, and AE Bengtson

Thirty-seven dogs with moderately differentiated, cutaneous mast cell tumors had incomplete surgical excisions as determined by histopathology, but no gross evidence of tumor. All dogs were irradiated to a total dose of between 46.2 and 48.0 Gy using either an orthovoltage source (n = 20) or a linear accelerator (megavoltage) (n = 17). Radiation was delivered to an area bordered by margins of 3 cm or greater around the surgical scar. The mast cell tumors had not recurred in 97% of dogs by one year after radiation therapy and had not recurred in 93% of dogs by three years after radiation. Both orthovoltage and megavoltage radiation provide excellent local control of moderately differentiated mast cell tumors in dogs.


This article has been cited by other articles:


Home page
 Journal of the American Animal Hospital AssociationHome page
V. J. Poirier, W. M. Adams, L. J. Forrest, E. M. Green, R. R. Dubielzig, and D. M. Vail
Radiation Therapy for Incompletely Excised Grade II Canine Mast Cell Tumors.
J. Am. Anim. Hosp. Assoc., November 1, 2006; 42(6): 430 - 434.
[Abstract] [Full Text] [PDF]

Home page
 Journal of the American Animal Hospital AssociationHome page
N. C. Northrup, R. E. Roberts, T. W. Harrell, K. L. Allen, E. W. Howerth, and T. L. Gieger
Iridium-192 Interstitial Brachytherapy as Adjunctive Treatment for Canine Cutaneous Mast Cell Tumors
J. Am. Anim. Hosp. Assoc., July 1, 2004; 40(4): 309 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Journal of the American Animal Hospital AssociationHome page
D. R. Davies, K. M. Wyatt, J. E. Jardine, I. D. Robertson, and P. J. Irwin
Vinblastine and Prednisolone as Adjunctive Therapy for Canine Cutaneous Mast Cell Tumors
J. Am. Anim. Hosp. Assoc., March 1, 2004; 40(2): 124 - 130.
[Abstract] [Full Text] [PDF]

Home page
 Journal of the American Animal Hospital AssociationHome page
L. E. Moore, L. D. Garrett, B. DeBey, and D. S. Biller
Spinal Mast Cell Tumor in a Dog
J. Am. Anim. Hosp. Assoc., January 1, 2002; 38(1): 67 - 70.
[Abstract] [Full Text] [PDF]

Home page
 Journal of the American Animal Hospital AssociationHome page
C. Weisse, F. S. Shofer, and K. Sorenmo
Recurrence Rates and Sites for Grade II Canine Cutaneous Mast Cell Tumors Following Complete Surgical Excision
J. Am. Anim. Hosp. Assoc., January 1, 2002; 38(1): 71 - 73.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Animal Hospital Association.